Back Daily Mail 23andMe inks deal with drug firm to develop antibody for skin conditions
Search Sections 8 Jul
Close
Advertisement
23andMe inks deal with drug firm to develop antibody for skin conditionsUpdated10 Jan 9:41am

23andMe inks deal with drug firm to develop antibody for skin conditions

Daily Mail
Spanish firm Almirall has bought the rights to turn the protein into viable anti-inflammatory medication for patients. It's the first time data collected by 23andMe will be used for drug development.
Read full story
 Like Comment
Advertisement

Comments

No comments yet...
On the top

Date settings

Today is Wednesday, July 8, 2020

+ 1 -
+ 1 -
+ 2016 -

Close

By using our website, you agree to the use of cookies as described in our cookie policy.

Accept

Daily Mail

Close